Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high‐dose chemotherapy + G‐CSF

British Journal of Haematology

Volumn 91, Issue 3, 1995, Pages 535-543

  Tarella, Corrado ^a   Benedetti, Giovanni ^a   Caracciolo, Daniele ^a   Castellino, Claudia ^a   Cherasco, Cristina ^a   Bondesan, Paola ^a   Omede, Paola ^a   Ruggieri, Daniela ^b   Gianni, Alessandro Massimo ^c   Pileri, Alessandro ^a  

^a Divisione Universitaria di Ematologia   (Italy)

^b R&D Immunology and Microbiology Department ^*  (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

haemopoietic progenitors; high dose chemotherapy + G CSF; LTC IC; mobilization; PB autograft

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION;

ADULT; BONE MARROW; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMAN; LYMPHOMA, NON-HODGKIN; MIDDLE AGE; MULTIPLE MYELOMA; PHENOTYPE; SUPPORT, NON-U.S. GOV'T;

EID: 0028858311     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb05344.x     Document Type: Article

References (46)

1. VAD‐based regimens as primary treatment for multiple myeloma
2. Kinetics of human hemopoietic cells after in vivo administration of granulocyte‐macrophage colony‐stimulating factor
3. Precursors of colony forming cells in human can be distinguished from colony forming cells by expression of the CD33 and CD34 antigens and light scatter properties
4. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens
5. Selection and characterization of early hemopoietic progenitors using an anti‐CD71/S06 immunotoxin
6. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte‐colony stimulating factor accelerate both neutrophil and platelet recovery after high‐dose VP16, ifosfamide and cisplatin
7. Effects of recombinant human granulocyte colony‐stimulating factor on hematopoietic progenitor cells in cancer patients
8. Peripheral blood stem cells reach new heights
9. Surface phenotype of human hemopoietic progenitor cells defined by monoclonal antibodies
10. High‐dose chemoradio‐therapy for sensitive tumors: is sequential better than concurrent drug delivery
11. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells: a changing role for high‐dose chemo‐radiotherapy
12. Granulocyte‐macrophage colony‐stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation
13. Durable and complete hematopoietic reconstitution after auto‐grafting of rhGM‐CSF exposed peripheral blood progenitor cells
14. Human long‐term bone marrow culture as a prognostic factor for hematopoietic reconstitution in autologous transplantation. Bone
15. + selected human peripheral blood progenitor cells
16. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG‐CSF
17. Peripheral blood and bone marrow hematopoietic stem cells: are they the same
18. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte‐colony stimulating factor
19. Effect of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony‐stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children
20. The evolving role of autologous peripheral stem cell transplantation following high‐dose therapy for malignancies
21. Kinetics of circulating haematopoietic progenitors during chemotherapy induced with or without granulocyte colony‐stimulating factor
22. The kinetics of human granulopoiesis following treatment with granulocyte colony‐stimulating factor in vitro
23. The engraftment capacity of peripheral blood progenitor cells mobilized with chemotherapy ±G‐CSF
24. Direct comparison by limiting dilution analysis of long‐term culture‐initiating cells in human bone marrow, umbilical cord blood, and blood stem cells
25. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non‐Hodgkin's lymphoma
26. Large‐scale collection of circulating hematopoietic progenitors in cancer patients treated with high‐dose cyclophosphamide and recombinant human GM‐CSF
27. + cells from patients with stage rv breast cancer
28. Effect of peripheral blood progenitor cells mobilized by filgrastim (G‐CSF) on platelet recovery after high‐dose chemotherapy
29. Changes in cell surface antigen expression during hemopoietic differentiation
30. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
31. Circulation of CD34‐positive hematopoietic stem cells in the peripheral blood of high‐dose cyclophosphamide treated patients: enhancement by intravenous recombinant human GM‐CSF
32. Surface molecules of human neutrophilic granulocytes identified by murine monoclonal antibodies
33. Granulocyte‐macrophage colony‐stimulating factor expands the circulating haemopoietic progenitor cell compartment in man
34. Characterization and partial purification of human marrow cells capable of initiating long‐term hematopoiesis in vitro
35. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants
36. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow
37. Peripheral blood expansion of early progenitor cells after high‐dose cyclophosphamide and rhGM‐CSF
38. Immunological separation of two CFU‐GM subsets showing different responsiveness to T‐cell derived growth factors
39. Limiting dilution assay for the determination of immunocompetent cell frequency
40. Granulocyte colony‐stimulating factor (G‐CSF)‐induced mobilization of circulating haemopoietic stem cells. British
41. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts
42. + hematopoietic stem cells
43. Effective salvage therapy for lymphoma with cisplatin in combination with high‐dose Ara‐C and dexamethasone (DHAP)
44. Effect of recombinant human granulocyte‐macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies
45. Long‐term results of the APO protocol (vincristin, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma